UBCare
UBCare (operating as GC MediAI) provides Korea's leading medical AI platform, connecting hospitals, clinics, pharmacies, pharma firms, and patients through its #1 domestic EMR system (의사랑) and integrated data analytics, pharmaceutical distribution, and chronic disease management services.
- Company typePrivate
- Founded1992
- HeadquartersSeoul, South Korea
- Headcount101–250
- GTM typeB2B
- OfferingSoftware
What UBCare does
UBCare, operating commercially as GC MediAI (주)GC메디아이), is a South Korean medical AI and healthcare IT company founded in 1992 and headquartered in Seoul's Seongdong-gu district. The company operates a platform-plus-modules architecture branded 'Medical OS' that connects hospitals, clinics, pharmacies, pharmaceutical manufacturers, and patients through four business segments: Medical Infrastructure (its market-leading 의사랑 EMR and 유팜 pharmacy management system, plus the 오토팩 pharmacy automation solution), Data & Marketing (prescription-data analytics for pharma/biotech, including the newly launched UBIST OTC general medication market analysis solution), Platform (patient-facing appointment booking and chronic disease management connected to EMR), and Distribution & Medical Devices (an integrated online-offline pharma and device distribution network).
The underlying technology combines proprietary EMR and pharmacy management software with prescription data aggregation across both outpatient and inpatient settings, enabling the company to monetize that data asset through subscription-based analytics products sold to pharmaceutical and biotech clients. The core revenue mechanics combine recurring EMR infrastructure licensing/support fees, data monetization, subscription platform services, and transaction-based distribution margins, with an enterprise field-sales motion targeting hospitals, clinics, and pharmacies and a product-led motion for newer solutions like UBIST OTC.
The company has raised approximately $72.4 million in a 2015 Series 4 led by STIC Investment plus a subsequent investment from Kakao Investment in 2018, employs 101-250 people, and maintains an active investor relations website that includes stock price information, indicating publicly traded equity. The strategic narrative centers on evolving from a single-product EMR vendor to an integrated 'Beyond EMR, Toward Medical OS' platform serving the entire Korean healthcare value chain.
UBCare firmographics
Firmographics- Name
- UBCare
- Legal name
- (주)GC메디아이
- Website
- https://ubcare.co.kr
- Company type
- Private
- Founded year
- 1992
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- UBCare (operating as GC MediAI) provides Korea's leading medical AI platform, connecting hospitals, clinics, pharmacies, pharma firms, and patients through its #1 domestic EMR system (의사랑) and integrated data analytics, pharmaceutical distribution, and chronic disease management services.
- Ownership category
- akta.pro rank
UBCare industry classification
Industry- Product category
- Healthcare IT / Medical AI Software
- NAICS
- Professional, Scientific, and Technical Services (54)
- SIC
- Services-Health Services (8000)
- akta.pro primary industry
- Medication Therapy Management (MTM) & Clinical Pharmacy Services Tools (HLACAKAH)
- akta.pro secondary industry
- Virtual Pharmacy & Medication Management Integration Platforms (HLALABAL)
Keywords
Where UBCare is headquartered
LocationHeadquarters
- HQ city
- Seoul
- HQ country
- South Korea
- HQ region
- Asia
Offices1 record
Markets served
UBCare business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain
Revenue model
- EMR Infrastructure Services: Revenue from providing and maintaining EMR systems (의사랑, 유팜) to hospitals, clinics, and pharmacies with subscription or licensing fees for software access and support services
- Data & Marketing Solutions: Pharmaceutical and biotech business insights generated from prescription data (both outpatient and inpatient), sold as data analytics solutions to pharmaceutical companies
- Platform Services: Patient-facing services through connected EMR platform including appointment booking and chronic disease management solutions
- Distribution & Medical Devices: Pharmaceutical and medical device distribution network connecting online and offline healthcare channels, providing consulting services to medical facilities
Go-to-market motion2 records
Distribution channels3 records
Marketing channels3 records
UBCare product offering
Product offeringCore offering
UBCare (via GC MediAI) provides Korea's leading EMR system 의사랑 and pharmacy management system 유팜, the AutoPack pharmacy automation solution, the UBIST OTC data analytics product for pharmaceutical market intelligence, and a Medical OS platform connecting hospitals, clinics, pharmacies, pharma/biotech firms, and patients. The offerings combine software infrastructure, prescription data analytics, and pharmaceutical/medical device distribution into an integrated Medical OS for the Korean healthcare ecosystem.
Product overview
GC메디아이 operates a platform-plus-modules architecture centered on Medical OS, combining medical infrastructure (의사랑 EMR and 유팜 pharmacy systems), data solutions (UBIST OTC), and a patient-facing platform for appointment booking and chronic disease management. The company connects hospitals, clinics, pharmacies, and patients through integrated medical AI technology.
Differentiator
Problem solved
Functional benefit
Products and services
- 의사랑 (Euisarang) EMR
Quantifiable outcome
- #1 EMR market position in Korea
- +1 more outcomes
Companies that use UBCare
Customer profileSegments4 records
Ideal customer profiles3 records
UBCare technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
UBCare partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered minor.
- 아이쿱 (iCup)minoriCup partnered with GC메디아이 and Ssure (씨어스) to expand smart bedside blood glucose management services. The partnership focuses on cooperation for spreading and expanding smart bedside blood sugar management technology in hospital settings.
- 씨어스 (Ssure)minorSsure collaborated with iCup (아이쿱) and GC메디아이 on the 'smart bedside blood glucose management expansion cooperation' MOU. The partnership aims to promote widespread adoption of smart blood glucose monitoring at patient bedsides in medical institutions.
Scale indicators1 record
Recent moves6 records
Expansion highlights5 records
UBCare competitors and assessment
Company assessmentBroad incumbents
- Athenahealth: Cloud-based EHR and healthcare IT platform with revenue-cycle and patient engagement tools; comparable in providing integrated software/data services to clinicians.
- MEDITECH: Established EMR vendor serving hospitals and ambulatory networks; comparable healthcare IT infrastructure competitor across hospital segments.
- Veradigm (formerly Allscripts): EHR and practice management vendor serving hospitals, physician practices, and pharmacies; comparable in covering both provider and pharmacy IT workflows.
- IQVIA: Global leader in healthcare data, analytics, and clinical research services for pharmaceutical companies; directly comparable to GC MediAI's data & marketing / prescription data monetisation business.
- Epic Systems: Dominant US-based EMR vendor used by large academic hospitals; represents the global benchmark for EMR scale and a credible competitor if Korean hospitals look to modernise platforms.
- Cerner / Oracle Health: Global EMR and healthcare IT incumbent serving hospitals worldwide; relevant as the large-scale EMR competitor that GC MediAI positions against when talking to multi-national hospital clients and large Korean systems.
Emerging players
- Veeva Systems: Cloud software and data platform serving life sciences and pharma; relevant comp for GC MediAI's prescription-data-driven insights sold to pharma/biotech customers.
Regional players
- M3 (Japan): Japanese medical information and physician platform; comparable Asian healthcare IT incumbent demonstrating cross-sell of physician data into pharma marketing — a relevant Asian comp for GC MediAI's data monetisation model.
- Medical Data Vision (Japan): Japanese provider of DPC/EHR-derived real-world healthcare data sold to pharma; offers a directly comparable business model to GC MediAI's prescription data monetisation for pharmaceutical customers, though operating in Japan rather than Korea.
Direct peers
- ezCaretech (이지케어텍): Another major Korean EMR/medical IT vendor competing with GC MediAI's 의사랑 for hospital and clinic contracts in South Korea. Direct overlap in Korean healthcare IT infrastructure.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
UBCare financial estimates
Financial estimateRevenue estimate
Valuation estimate
UBCare leadership team
Management profileNumber of profiles
Profiles1 record
UBCare funding detail
Funding detailFunding overview
Funding rounds2 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
UBCare M&A and investment
M&A and investmentM&A
Investments1 record
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about UBCare
What does UBCare do?
UBCare (via GC MediAI) provides Korea's leading EMR system 의사랑 and pharmacy management system 유팜, the AutoPack pharmacy automation solution, the UBIST OTC data analytics product for pharmaceutical market intelligence, and a Medical OS platform connecting hospitals, clinics, pharmacies, pharma/biotech firms, and patients. The offerings combine software infrastructure, prescription data analytics, and pharmaceutical/medical device distribution into an integrated Medical OS for the Korean healthcare ecosystem.
Is UBCare a public or private company?
UBCare is a private company. It is classified as venture growth investor backed and is currently operating.
When was UBCare founded?
UBCare was founded in 1992. It employs 101 to 250 people.
Where is UBCare based?
UBCare is headquartered in Seoul, South Korea, in the Asia region.
How does UBCare make money?
Four revenue lines are on record. EMR Infrastructure Services are the primary driver. The others are data & Marketing Solutions, platform Services and distribution & Medical Devices.
Who are UBCare's main competitors?
Broad incumbents on record are Athenahealth, MEDITECH, Veradigm (formerly Allscripts), IQVIA, Epic Systems and Cerner / Oracle Health. Veeva Systems is listed as an emerging player. Regional players are M3 (Japan) and Medical Data Vision (Japan). ezCaretech (이지케어텍) is listed as a direct peer.
Does UBCare have an API?
No public API is recorded for UBCare.
What industry is UBCare in?
UBCare's product category is Healthcare IT / Medical AI Software. Its primary akta.pro industry code is HLACAKAH, Medication Therapy Management (MTM) & Clinical Pharmacy Services Tools, with a secondary code of HLALABAL, Virtual Pharmacy & Medication Management Integration Platforms. Its NAICS code is 54 and its SIC code is 8000.